Dose escalation and pharmacokinetic study of nanoparticle curcumin⋯ by Kanai et al., CCP 69:65-70, 2012

Cancer Chemotherapy and Pharmacology

Volumn 70, Issue 3, 2012, Pages 487-

  Gescher, Andreas J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; CURCUMIN; DRUG METABOLITE; NANOPARTICLE; THERACURCUMIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BLOOD SAMPLING; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG FORMULATION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; NANOPHARMACEUTICS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CURCUMIN; FEMALE; HUMANS; MALE; NANOPARTICLES;

EID: 84866389891     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-012-1927-6     Document Type: Letter

References (1)

1. KanaiM, Imaizumi A, Otsuka Y, Sasaki H, HashiguchiM, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T (2011) Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother Pharmacol 69:65-70